Search SHS

Ragy Girgis, MD, MS



Ragy Girgis, MD joined the Columbia University Medical Center (CUMC) Student Health Service in 2009. Prior to joining SHS, Dr. Girgis completed his medical school training at the University of Pittsburgh School of Medicine, and his residency in psychiatry at Columbia University.

Dr. Girgis is an Assistant Professor of Psychiatry at CUMC and the Director of the Center of Prevention and Evaluation (COPE), Columbia’s prodromal psychosis research clinic.  His research interests are using Positron Emission Tomography (PET) imaging and clinical trials to develop novel medications for the treatment of schizophrenia.


  • B.S. University of Missouri-Rolla
  • M.D., University of Pittsburgh
  • M.S. Columbia University

Certifications & Licensure

  • Certified by the American Board of Psychiatry and Neurology
  • Licensed to practice medicine in the State of New York

Professional Experience

  • Director, The Center of Prevention and Evaluation (COPE), New York State Psychiatric Institute
  • Staff Psychiatrist, CUMC SHS Mental Health Service

Published Articles (Recent)

  • Ragy R. Girgis, Michael R. Phillips, Xiaodong Li, Kejing Li, Huiping Jiang, Chengjing Wu, Naihua Duan, Yajuan Niu, Jeffrey A. Lieberman. Clozapine vs chlorpromazine in treatment-naïve, first-episode schizophrenia: 9 year follow-up results from a randomized clinical trial. British Journal of Psychiatry, 2011 Oct; 199(4):281-8.
  • Ragy R. Girgis, Xiaoyan Xu, Nobumi Miyake, Balu Easwaramoorthy, Roger N. Gunn, Eugenii A. Rabiner, Anissa Abi-Dargham, Mark Slifstein. In Vivo Binding Of Antipsychotics To D3 And D2 Receptors: A PET Study In Baboons With [11C]-(+)-PHNO. Neuropsychopharmacology, 2011 Mar;36(4):887-95.
  • S. Lucy Poe, Kelly E. Gill, Gary Brucato, Cheryl M. Corcoran, Ragy R. Girgis. Family history of psychosis as a predictor or protective factor of social maladjustment in a population at clinical high risk for psychosis. Psychiatry Research, in press.
  • Ragy R. Girgis, Samhita S. Kumar, Alan S. Brown. The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies. Biological Psychiatry, in press.
  • EMP. Poels, LS Kegeles, JT Kantrowitz, DC Javitt, JA Lieberman, A Abi-Dargham, RR Girgis. Glutamatergic Abnormalities In Schizophrenia: a review of proton MRS findings. Schizophrenia Research, in press.

Awards and Honors (Recent)

  • Irving Institute Collaborative and Multidisciplinary Pilot Research award for Basic Science and Clinical/Translational Investigators (CaMPR-BASIC) for “The Relationship Between Prenatal Immune Activation and Basal Metabolism in the Adolescent Hippocampus.” (2014)
  • Irving Institute/Clinical Trials Office (CTO) Pilot Award (2012)
  • TRANSFORM KL2 Mentored Career Development Award (2012)
  • ACNP Young Investigator Memorial Travel Awardee (2011)
  • Gray Matters at Columbia Fellowship Recipient (2011)


  • American Psychiatric Association
  • New York State Psychiatric Association